SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | AVADEL PHARMACEUTICALS PLC | 9,196,186 | 10.0% | EDGAR |
SC 13G/A | 2024-02-13 | GENDELL JEFFREY L | AVADEL PHARMACEUTICALS PLC | 3,539,782 | 3.9% | EDGAR |
SC 13G/A | 2024-02-13 | JANUS HENDERSON GROUP PLC | AVADEL PHARMACEUTICALS PLC | 11,125,330 | 12.4% | EDGAR |
SC 13G | 2024-02-13 | Polar Capital Holdings Plc | AVADEL PHARMACEUTICALS PLC | 6,751,782 | 7.5% | EDGAR |
SC 13G/A | 2024-02-12 | KOTLER KEVIN | AVADEL PHARMACEUTICALS PLC | 3,716,242 | 4.1% | EDGAR |
SC 13G | 2023-08-10 | JANUS HENDERSON GROUP PLC | AVADEL PHARMACEUTICALS PLC | 9,443,642 | 12.3% | EDGAR |
SC 13G | 2023-03-09 | KOTLER KEVIN | AVADEL PHARMACEUTICALS PLC | 3,122,100 | 5.1% | EDGAR |
SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | AVADEL PHARMACEUTICALS PLC | 5,741,939 | 9.3% | EDGAR |
SC 13G/A | 2023-02-14 | Vivo Opportunity, LLC | AVADEL PHARMACEUTICALS PLC | 2,251,663 | 3.6% | EDGAR |
SC 13G/A | 2023-02-14 | GENDELL JEFFREY L | AVADEL PHARMACEUTICALS PLC | 3,294,817 | 5.3% | EDGAR |
SC 13G/A | 2023-02-13 | KOTLER KEVIN | AVADEL PHARMACEUTICALS PLC | 2,856,990 | 4.6% | EDGAR |
SC 13G | 2022-06-06 | KOTLER KEVIN | AVADEL PHARMACEUTICALS PLC | 3,440,212 | 5.8% | EDGAR |
SC 13G | 2022-06-03 | GENDELL JEFFREY L | AVADEL PHARMACEUTICALS PLC | 2,906,665 | 4.9% | EDGAR |
SC 13G/A | 2022-02-14 | RTW INVESTMENTS, LP | AVADEL PHARMACEUTICALS PLC | 5,810,140 | 10.0% | EDGAR |
SC 13G/A | 2022-02-14 | Polar Capital Holdings Plc | AVADEL PHARMACEUTICALS PLC | 2,794,673 | 4.8% | EDGAR |
SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | AVADEL PHARMACEUTICALS PLC | 1,670,000 | 2.9% | EDGAR |
SC 13G/A | 2022-02-11 | Vivo Opportunity, LLC | AVADEL PHARMACEUTICALS PLC | 2,401,276 | 4.1% | EDGAR |
SC 13G/A | 2022-02-08 | BRANDES INVESTMENT PARTNERS, LP | AVADEL PHARMACEUTICALS PLC | 2,599,633 | 4.4% | EDGAR |
SC 13G/A | 2022-01-21 | COWEN AND COMPANY, LLC | AVADEL PHARMACEUTICALS PLC | 0 | 0.0% | EDGAR |
SC 13G | 2021-11-12 | COWEN AND COMPANY, LLC | AVADEL PHARMACEUTICALS PLC | 42,000 | 0.1% | EDGAR |